Non-Homogeneous Floor-of-Mouth Patch in a Smoker
A 62-year-old man presents with a 2.5 cm white and red patch on the left floor of the mouth that has been present for 6 months. He has smoked 20 cigarettes/day for 35 years and drinks alcohol on weekends. The lesion is non-homogeneous, slightly tender, and not indurated. There is no cervical lymphadenopathy. He has no history of oral cancer. He asks whether the patch can be watched for another 3 months because it does not hurt much. He has noticed no bleeding, but the lesion has enlarged from 1 cm 3 months ago. His wife has a history of breast cancer. He takes no medications. He is a retired teacher and is worried about missing work for a biopsy. He has no dysphagia or otalgia.
1. Should this lesion be observed or biopsied? Justify your answer using the clinical features and the concept of oral potentially malignant disorders.
Read the worked answer
It should be biopsied, not observed. The floor of the mouth is a high-risk site for oral squamous cell carcinoma. The lesion is non-homogeneous, has been present for 6 months, and has enlarged from 1 cm to 2.5 cm. He has two major risk factors-35 pack-years of smoking and alcohol use. Lack of induration and mild tenderness do not exclude dysplasia or early carcinoma; early lesions can be flat. The concept of oral potentially malignant disorders means that a persistent white and red patch carries a risk of transformation, and observation for another 3 months would delay diagnosis. The correct judgment is an incisional biopsy from the most suspicious area, including the red/white junction, not an excisional biopsy as the first step. He should be referred for oral medicine or oral and maxillofacial surgery review.
2. Describe the histologic features you would report and how they influence management.
Read the worked answer
The pathologist should describe architectural and cytologic features of epithelial dysplasia: irregular stratification, drop-shaped rete ridges, loss of basal cell polarity, nuclear pleomorphism, hyperchromasia, increased nuclear-to-cytoplasmic ratio, mitoses (including atypical mitoses), and dyskeratosis. The grade is mild, moderate, or severe, with carcinoma in situ if the full thickness is involved but the basement membrane is intact. If invasive carcinoma is present, the depth of invasion and pattern of invasion matter. Management follows the grade: mild dysplasia may be managed by excision or close follow-up after risk-factor cessation; moderate to severe dysplasia or carcinoma in situ requires excision with clear margins and frequent review. The judgment is that the biopsy result changes the surgeon from a watcher to an exciser, and the grade determines margins and follow-up intensity.
3. What molecular and behavioral factors would you discuss with him regarding malignant transformation?
Read the worked answer
I would explain that smoking and alcohol act synergistically, and that field cancerization means the whole upper aerodigestive mucosa is at risk, not just the visible patch. Molecular changes include TP53 mutation, loss of heterozygosity at 3p and 9p, cyclin D1 amplification, and EGFR overexpression; these accumulate with dysplasia. Cessation of smoking and alcohol reduces but does not eliminate risk. He needs follow-up every 3 months initially, with biopsy of any new induration, ulceration, or enlargement. The judgment is to counsel him that the patch is a warning, not a cosmetic problem, and that surveillance is part of the treatment. His wife's breast cancer history is not directly relevant, but his anxiety about missing work should be addressed by scheduling the biopsy efficiently.